Source link : https://www.newshealth.biz/health-news/acromegaly-injectable-rejected-nobel-prize-winner-dies-obesity-doubles-in-kids/
The FDA declined to approve investigational octreotide (CAM2029) extended-release injection for acromegaly, said developer Camurus, citing facility-related deficiencies identified during an inspection of a third-party manufacturer. Paternal use of metformin for type 2 diabetes during sperm development wasn’t tied with congenital malformations in offspring, a study of over 3 million pregnancies found. (The BMJ) In […]
Author : News Health
Publish date : 2024-10-22 18:56:00
Copyright for syndicated content belongs to the linked Source.